Twist Accounts Payable from 2010 to 2024
TWST Stock | USD 43.62 0.99 2.22% |
Accounts Payable | First Reported 2016-09-30 | Previous Quarter 6.6 M | Current Value 1.6 M | Quarterly Volatility 5.9 M |
Check Twist Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Twist Bioscience's main balance sheet or income statement drivers, such as Tax Provision of 588 K, Net Interest Income of 16.1 M or Interest Income of 16.1 M, as well as many indicators such as Price To Sales Ratio of 7.96, Dividend Yield of 0.0 or PTB Ratio of 5.82. Twist financial statements analysis is a perfect complement when working with Twist Bioscience Valuation or Volatility modules.
Twist | Accounts Payable |
Latest Twist Bioscience's Accounts Payable Growth Pattern
Below is the plot of the Accounts Payable of Twist Bioscience Corp over the last few years. An accounting item on the balance sheet that represents Twist Bioscience obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Twist Bioscience Corp are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Twist Bioscience's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Twist Bioscience's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable | 10 Years Trend |
|
Accounts Payable |
Timeline |
Twist Accounts Payable Regression Statistics
Arithmetic Mean | 6,080,967 | |
Geometric Mean | 4,132,340 | |
Coefficient Of Variation | 97.26 | |
Mean Deviation | 4,790,689 | |
Median | 2,337,000 | |
Standard Deviation | 5,914,439 | |
Sample Variance | 35T | |
Range | 18.5M | |
R-Value | 0.46 | |
Mean Square Error | 29.8T | |
R-Squared | 0.21 | |
Significance | 0.09 | |
Slope | 605,070 | |
Total Sum of Squares | 489.7T |
Twist Accounts Payable History
About Twist Bioscience Financial Statements
Twist Bioscience shareholders use historical fundamental indicators, such as Accounts Payable, to determine how well the company is positioned to perform in the future. Although Twist Bioscience investors may analyze each financial statement separately, they are all interrelated. The changes in Twist Bioscience's assets and liabilities, for example, are also reflected in the revenues and expenses on on Twist Bioscience's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last Reported | Projected for Next Year | ||
Accounts Payable | 1.6 M | 1.5 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Twist Stock Analysis
When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.